Chemoprevention Of Lung Cancer: Diagnosis And Management Of Lung Cancer
Publication Date: May 1, 2013
Last Updated: March 14, 2022
Recommendations
Agents Tested in Chemoprevention Trials (With Lung Cancer as an End Point)
For individuals with a greater than 20 pack year history of smoking or with a history of lung cancer, the use of β carotene supplementation is not recommended for primary, secondary, or tertiary chemoprevention of lung cancer. (1, A)
307795
For individuals at risk for lung cancer and for patients with a history of lung cancer, the use of vitamin E, retinoids, and N-acetylcysteine and isotretinoin is not recommended for primary, secondary, or tertiary prevention of lung cancer. (1, A)
307795
For individuals at risk for lung cancer and for patients with a history of lung cancer, the use of aspirin is not recommended for primary, secondary, or tertiary prevention of lung cancer (outside of the setting of a well-designed clinical trial). (2, B)
307795
In individuals with a history of early stage NSCLC, the use of selenium as a tertiary chemopreventive agent of lung cancer is not recommended. (1, B)
307795
Title
Chemoprevention Of Lung Cancer: Diagnosis And Management Of Lung Cancer
Authoring Organization
American College of Chest Physicians